These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34174217)

  • 41. Visit-to-visit low-density lipoprotein cholesterol variability and risk of cardiovascular outcomes: insights from the TNT trial.
    Bangalore S; Breazna A; DeMicco DA; Wun CC; Messerli FH;
    J Am Coll Cardiol; 2015 Apr; 65(15):1539-48. PubMed ID: 25881936
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD.
    Koren MJ; Davidson MH; Wilson DJ; Fayyad RS; Zuckerman A; Reed DP;
    Am J Kidney Dis; 2009 May; 53(5):741-50. PubMed ID: 19216014
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Benefits of Icosapent Ethyl Across the Range of Kidney Function in Patients With Established Cardiovascular Disease or Diabetes: REDUCE-IT RENAL.
    Majithia A; Bhatt DL; Friedman AN; Miller M; Steg PG; Brinton EA; Jacobson TA; Ketchum SB; Juliano RA; Jiao L; Doyle RT; Granowitz C; Budoff M; Preston Mason R; Tardif JC; Boden WE; Ballantyne CM
    Circulation; 2021 Nov; 144(22):1750-1759. PubMed ID: 34706555
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aspirin for Primary Prevention of Cardiovascular Disease and Renal Disease Progression in Chronic Kidney Disease Patients: a Multicenter Randomized Clinical Trial (AASER Study).
    Goicoechea M; de Vinuesa SG; Quiroga B; Verde E; Bernis C; Morales E; Fernández-Juárez G; de Sequera P; Verdalles U; Delgado R; Torres A; Arroyo D; Abad S; Ortiz A; Luño J
    Cardiovasc Drugs Ther; 2018 Jun; 32(3):255-263. PubMed ID: 29943364
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Remnant Lipoproteins Are Residual Risk Factor for Future Cardiovascular Events in Patients With Stable Coronary Artery Disease and On-Statin Low-Density Lipoprotein Cholesterol Levels <70 mg/dL.
    Fujihara Y; Nakamura T; Horikoshi T; Obata JE; Fujioka D; Watanabe Y; Watanabe K; Kugiyama K
    Circ J; 2019 May; 83(6):1302-1308. PubMed ID: 30996151
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial.
    Pedersen TR; Faergeman O; Kastelein JJ; Olsson AG; Tikkanen MJ; Holme I; Larsen ML; Bendiksen FS; Lindahl C; Szarek M; Tsai J;
    JAMA; 2005 Nov; 294(19):2437-45. PubMed ID: 16287954
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.
    Ridker PM; Danielson E; Fonseca FA; Genest J; Gotto AM; Kastelein JJ; Koenig W; Libby P; Lorenzatti AJ; MacFadyen JG; Nordestgaard BG; Shepherd J; Willerson JT; Glynn RJ;
    N Engl J Med; 2008 Nov; 359(21):2195-207. PubMed ID: 18997196
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of alirocumab on major adverse cardiovascular events according to renal function in patients with a recent acute coronary syndrome: prespecified analysis from the ODYSSEY OUTCOMES randomized clinical trial.
    Tuñón J; Steg PG; Bhatt DL; Bittner VA; Díaz R; Goodman SG; Jukema JW; Kim YU; Li QH; Mueller C; Parkhomenko A; Pordy R; Sritara P; Szarek M; White HD; Zeiher AM; Schwartz GG;
    Eur Heart J; 2020 Nov; 41(42):4114-4123. PubMed ID: 32820320
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Baseline low-density lipoprotein cholesterol predicts the benefit of adding ezetimibe on statin in statin-naïve acute coronary syndrome.
    Im J; Kawada-Watanabe E; Yamaguchi J; Arashi H; Otsuki H; Matsui Y; Sekiguchi H; Fujii S; Mori F; Ogawa H; Hagiwara N
    Sci Rep; 2021 Apr; 11(1):7480. PubMed ID: 33820931
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study).
    Hiro T; Kimura T; Morimoto T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Kimura K; Saito S; Yamaguchi T; Daida H; Matsuzaki M;
    J Am Coll Cardiol; 2009 Jul; 54(4):293-302. PubMed ID: 19608026
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An evaluation of pitavastatin for the treatment of hypercholesterolemia.
    Chan P; Shao L; Tomlinson B; Zhang Y; Liu ZM
    Expert Opin Pharmacother; 2019 Jan; 20(1):103-113. PubMed ID: 30482061
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oxidized low-density lipoprotein cholesterol and the ratio in the diagnosis and evaluation of therapeutic effect in patients with coronary artery disease.
    Huang H; Ma R; Liu D; Liu C; Ma Y; Mai W; Dong Y
    Dis Markers; 2012; 33(6):295-302. PubMed ID: 23089925
    [TBL] [Abstract][Full Text] [Related]  

  • 53. C-reactive protein, but not low-density lipoprotein cholesterol levels, associate with coronary atheroma regression and cardiovascular events after maximally intensive statin therapy.
    Puri R; Nissen SE; Libby P; Shao M; Ballantyne CM; Barter PJ; Chapman MJ; Erbel R; Raichlen JS; Uno K; Kataoka Y; Nicholls SJ
    Circulation; 2013 Nov; 128(22):2395-403. PubMed ID: 24043299
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of statins on serum n-3 to n-6 polyunsaturated fatty acid ratios in patients with coronary artery disease.
    Nozue T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Sato A; Nozato T; Miyake S; Takeyama Y; Morino Y; Yamauchi T; Muramatsu T; Hibi K; Michishita I
    J Cardiovasc Pharmacol Ther; 2013 Jul; 18(4):320-6. PubMed ID: 23324995
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Add-on ezetimibe treatment to low-dose statins vs medium-intensity statin monotherapy in coronary artery disease patients with poorly controlled dyslipidemia.
    Sakuma M; Toyoda S; Hashimoto R; Yazawa H; Masuyama T; Hirose S; Waku R; Hasumi H; Numao T; Abe S; Inoue T
    Hypertens Res; 2019 Dec; 42(12):1923-1931. PubMed ID: 31409915
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of reduced renal function on prognosis in Japanese patients with coronary artery disease: a prospective cohort of Shinken Database 2007.
    Nakamura M; Yamashita T; Yajima J; Oikawa Y; Ogasawara K; Kirigaya H; Sagara K; Koike A; Sawada H; Aizawa T
    Hypertens Res; 2009 Oct; 32(10):920-6. PubMed ID: 19696780
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study.
    Shepherd J; Kastelein JJ; Bittner V; Deedwania P; Breazna A; Dobson S; Wilson DJ; Zuckerman A; Wenger NK;
    J Am Coll Cardiol; 2008 Apr; 51(15):1448-54. PubMed ID: 18402899
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials.
    ; Herrington WG; Emberson J; Mihaylova B; Blackwell L; Reith C; Solbu MD; Mark PB; Fellström B; Jardine AG; Wanner C; Holdaas H; Fulcher J; Haynes R; Landray MJ; Keech A; Simes J; Collins R; Baigent C
    Lancet Diabetes Endocrinol; 2016 Oct; 4(10):829-39. PubMed ID: 27477773
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Trial of Pitavastatin Versus Rosuvastatin for Dyslipidemia in Chronic Kidney Disease.
    Abe M; Maruyama N; Maruyama T; Okada K; Soma M
    J Atheroscler Thromb; 2015; 22(12):1235-47. PubMed ID: 26156625
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of the Mean Amplitude of Glycemic Excursions and Vascular Endothelial Dysfunction on Cardiovascular Events in Nondiabetic Patients With Coronary Artery Disease.
    Akasaka T; Sueta D; Tabata N; Takashio S; Yamamoto E; Izumiya Y; Tsujita K; Kojima S; Kaikita K; Matsui K; Hokimoto S
    J Am Heart Assoc; 2017 Apr; 6(5):. PubMed ID: 28446494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.